Faced with the risk of future epidemic waves, many countries are planning a new booster dose of anti-Covid vaccine for certain adults.
At the same time, the United States also intends to speed up the vaccination of… very young children.
Experts convened by the Food and Drug Administration (FDA) meet this Wednesday to consider the requests of Pfizer / BioNTech and Moderna to authorize their vaccine in toddlers (from 6 months to 5 years for the first, from 6 months to 4 years for the second).
Subscribe to read more
Already subscribed?
To log in